$7.61
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The company is headquartered in New York City, New York. The company went IPO on 2025-12-03. The firm is focused on accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. The Company’s subsidiary is Sonnet BioTherapeutics Holdings, Inc., which is an oncology-focused biotechnology company with a proprietary platform for innovating biologic drugs of single or bifunctional action.
Country

US

CEO

Mr. David Schamis

IPO date

2025

Employees

0

ISIN

US44916Y1064

Website

-

Key stats

Open

$7.74

Volume

8.51M

Market cap

$1.49B

Prev. close

$7.56

Impl / hst vl

-

Open interest

$0.00

$7.50

Day’s Range

$8.21

$3.24

52W Range

$11.62

Valuation

27
Valuation score
Overvalued
P/E
-
P/S
-
P/B
2.00
Current ratio
18.22
Debt / Equity
-0.15
ROE
-
Gross margin
-
Income growth
-141.25%
FCF growth
-

Analysts estimates

Consensus rating
Buy

The average rating from top 6 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$9.10
The top 5 analysts forecasts that 12-month price may increase by 19.51%, with a low of $6.06 and a high of $11.55
$6.06
Low
$9.10
Avg
$11.55
High
Current price

Earnings

Q1 ‘26 revenue
$2.63M
Q1 ‘26 net income
$125.59M
Revenue
Net income
Previous EPS
-
Estimate EPS
$0.00
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply